The Europe embolization coils market is expected to grow from US$ 310.02 million in 2022 to US$ 391.22 million by 2028; it is estimated to grow at a CAGR of 4.0% from 2022 to 2028.
Escalation in Patient Preference for Minimally Invasive Procedures
The number of minimally invasive surgeries is rising as patients increasingly prefer such surgeries due to lesser postoperative pain, postoperative complications, shorter hospital stays, fast recovery times, etc. Noninvasive or minimally invasive treatments are being developed as alternatives to surgery for patients with early-stage breast cancer. For instance, Trans Arterial Chemo Embolization, also known as TACE, is a minimally invasive procedure that is typically used to treat hepatocellular carcinoma. TACE is for patients with asymptomatic and unresectable liver cancer. TACE can be used to diminish the size of the tumor and make the patient eligible for liver transplantation. It is considered an evolution from a formerly applied technique called Trans-Catheter Arterial Embolization (TAE). Bleeding is a common issue in cancer patients, related to local tumor invasion, tumor angiogenesis, systemic effects of cancer, or anti-cancer treatments. TACE involves a two-step process—selective arterial occlusion restricts the blood supply to the tumor, which causes ischemic tumor necrosis, and regional chemotherapy is arranged that helps the drug to remain in the area for a prolonged period, which starts causing the therapeutic effects. Prostatic artery embolization (PAE) is also a minimally invasive therapy implemented as an elective outpatient technique for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). The number of patients treated with PAE has grown in recent years. Thus, the increasing preference for minimally invasive procedures is fueling the embolization coils market growth. In Addition, the rise in the awareness about minimally invasive procedures and availability of the reimbursement for minimally invasive procedures are likely to foster the demand for a minimally invasive procedure. Thus, owing to these factors the Europe embolization coils market is likely to propel significantly in the forecast period.
Europe Embolization Coils Market Overview
The Europe embolization coils market includes France, Germany, United Kingdom, Italy, Spain, and Rest of Europe. Europe occupies second position in the global embolization coils market and is expected to register robust growth rate over the forecast period. The market is expected to witness robust growth due to the rising prevalence of the renal cancer in Germany and increasing numbers of the investments by the governments of France and United Kingdom. In addition, the rise in the prevalence of stroke is likely to drive the market significantly in the coming future.
Europe Embolization Coils Market Revenue and Forecast to 2028 (US$ Million)
Europe Embolization Coils Market Segmentation
The Europe embolization coils market is segmented on the basis of type, material, application, end user, and country. Based on type, the Europe embolization coils market is bifurcated into detachable coil and pushable coil. The detachable coil segment held a larger market share in 2022.
Based on material, the Europe embolization coils market is segmented into platinum, platinum & hydrogel, and platinum tungsten alloy. The platinum segment held the largest market share in 2022.
Based on application, the Europe embolization coils market is segmented into neurology, cardiology, urology, oncology, peripheral vascular disease, and others. The neurology segment held the largest market share in 2022.
Based on end user, the Europe embolization coils market is segmented into hospital, cardiac center, ambulatory center, and other. The hospital segment held the largest market share in 2022.
Based on country, the Europe embolization coils market is segmented into Germany, the UK, France, Italy, Spain, and Rest of Europe. The Germany dominated the market share in 2022.
Terumo Corporation; Medtronic; Boston Scientific Corporation; Stryker; KANEKA CORPORATION; MicroPort Scientific Corporation; Penumbra, Inc.; Cook Medical LLC; Johnson & Johnson Services, Inc.; and Shape Memory Medical INC. are the leading companies operating in the Europe embolization coils market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 310.02 Million |
| Market Size by 2028 | US$ 391.22 Million |
| CAGR (2022 - 2028) | 4.0% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By Type
|
| Regions and Countries Covered |
Europe
|
| Market leaders and key company profiles |
|
The Europe Embolization Coils Market is valued at US$ 310.02 Million in 2022, it is projected to reach US$ 391.22 Million by 2028.
As per our report Europe Embolization Coils Market, the market size is valued at US$ 310.02 Million in 2022, projecting it to reach US$ 391.22 Million by 2028. This translates to a CAGR of approximately 4.0% during the forecast period.
The Europe Embolization Coils Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Embolization Coils Market report:
The Europe Embolization Coils Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Embolization Coils Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Embolization Coils Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Embolization Coils Market
